UPDATE 4-Elan seeks acquisitions after $3.25 bln Biogen deal

[Reuters – UK Focus] – Irish drugmaker Elan israising more than $3.25 billion by selling its interests in itsmain drug and will splash out most of the proceeds onacquisitions, effectively reinventing itself as a company. Under … more

View todays social media effects on ALKS

View the latest stocks trending across Twitter. Click to view dashboard

See who Alkermes is hiring next, click here to view